Prosecution Insights
Prosecution Insights
12 pending office actions • 9 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (33%) |
| §112 only | 1 (8%) |
| Double-patenting + other | 3 (25%) |
| Multi-statute (no §101) | 4 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GALSTER, SAMUEL LEONARD | 1 | 52.3% | +41.7% |
| CHEN, PO-CHIH | 1 | 74.3% | +14.4% |
| YOO, SUN JAE | 1 | 71.0% | +0.3% |
| LADD, CAROLYN LOUISE | 1 | 57.0% | +47.9% |
| ROONEY, NORA MAUREEN | 1 | 60.2% | +23.8% |
| SIMMONS, CHRIS E | 1 | 34.5% | +19.3% |
| BREDEFELD, RACHAEL EVA | 1 | 27.5% | +34.8% |
| ISMAIL, REHANA | 1 | 77.3% | +32.8% |
| BERHANE, SELAM | 1 | 59.0% | +55.8% |
| BUTTICE, AUDREY L | 1 | 47.1% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028039 | PHARMACEUTICAL COMPOSITION | ROONEY, NORA MAUREEN | 133d overdue |
| 17757825 | METHOD FOR PRODUCING ERIBULIN-BASED ANTIBODY-DRUG CONJUGATE | BUTTICE, AUDREY L | 37d overdue |
| 19272275 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | GALSTER, SAMUEL LEONARD | — |
| 18292743 | METHOD FOR PRODUCING MONOCYCLIC PYRIDINE DERIVATIVE | YOO, SUN JAE | — |
| 18188249 | APICOMPLEXAN PARASITE INHIBITION | BREDEFELD, RACHAEL EVA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028039 | PHARMACEUTICAL COMPOSITION | ROONEY, NORA MAUREEN | 133d overdue |
| 17757825 | METHOD FOR PRODUCING ERIBULIN-BASED ANTIBODY-DRUG CONJUGATE | BUTTICE, AUDREY L | 37d overdue |
| 18030207 | PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS | LADD, CAROLYN LOUISE | 28d |
| 18188716 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | SIMMONS, CHRIS E | 42d |
| 19272275 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | GALSTER, SAMUEL LEONARD | — |
| 18846909 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | CHEN, PO-CHIH | — |
| 18188249 | APICOMPLEXAN PARASITE INHIBITION | BREDEFELD, RACHAEL EVA | — |
| 18009115 | METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A HIF-2 ALPHA INHIBITOR AND LENVATINIB | ISMAIL, REHANA | — |
| Art Unit | Apps |
|---|---|
| 1622 | 3 |
| 1693 | 1 |
| 1621 | 1 |
| 1641 | 1 |
| 3786 | 1 |
| 1625 | 1 |
| 1675 | 1 |
| 1647 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19272275 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | GALSTER, SAMUEL LEONARD | 1693 | §103§112 | Non-Final OA | — | Pending | Jul 17, 2025 |
| 18846909 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | CHEN, PO-CHIH | — | §103 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18292743 | METHOD FOR PRODUCING MONOCYCLIC PYRIDINE DERIVATIVE | YOO, SUN JAE | 1621 | §102§103 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18030207 | PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS | LADD, CAROLYN LOUISE | 1622 | §112 | Non-Final OA | 28d | Pending | Apr 04, 2023 |
| 18028039 | PHARMACEUTICAL COMPOSITION | ROONEY, NORA MAUREEN | 1641 | §103§112 | Final Rejection | 133d overdue | Pending | Mar 23, 2023 |
| 18188716 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | SIMMONS, CHRIS E | 1622 | §103Other | Non-Final OA | 42d | Pending | Mar 23, 2023 |
| 18188249 | APICOMPLEXAN PARASITE INHIBITION | BREDEFELD, RACHAEL EVA | 3786 | §103DP | Non-Final OA | — | Pending | Mar 22, 2023 |
| 18009115 | METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A HIF-2 ALPHA INHIBITOR AND LENVATINIB | ISMAIL, REHANA | 1625 | §103DP | Final Rejection | — | Pending | Dec 08, 2022 |
| 17906660 | HIGH CONCENTRATION ANTI-Abeta PROTOFIBRIL ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF | BERHANE, SELAM | 1675 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17757825 | METHOD FOR PRODUCING ERIBULIN-BASED ANTIBODY-DRUG CONJUGATE | BUTTICE, AUDREY L | 1647 | §102§103Other | Final Rejection | 37d overdue | Pending | Jun 21, 2022 |
| 17757672 | USE OF LEMBOREXANT FOR TREATING INSOMNIA | MOU, LIYUAN | 1628 | §103DP | Non-Final OA | — | Pending | Jun 17, 2022 |
| 17443650 | METHODS OF TREATING CIRCADIAN RHYTHM SLEEP DISORDERS | JAVANMARD, SAHAR | 1622 | §103Other | Non-Final OA | 8d overdue | Pending | Jul 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial